Literature DB >> 1737744

Inactivation of endothelin I by deamidase (lysosomal protective protein).

H L Jackman1, P W Morris, P A Deddish, R A Skidgel, E G Erdös.   

Abstract

Deamidase cleaves ester and peptide bonds in various substrates and deamidates protected COOH-terminal amino acids. It preferentially hydrolyzes peptides which contain hydrophobic amino acids in the P1' and/or P1 position. Because the COOH-terminal end of endothelin I contains the hydrophobic sequence -Ile19-Ile20-Trp21-OH, we investigated whether human deamidase, purified from platelets, could inactivate this peptide. We found that deamidase readily cleaved off Trp21 with an acid pH optimum, a Km = 22 microM, a kcat of 1454 min-1, and a kcat/Km of 68 microM-1 min-1. We also found the enzyme to be present in target cells of endothelin, in vascular smooth muscle cells. Extracts of cultured vascular smooth muscle cells cleave both the synthetic fluorescent substrate 5-dimethylaminonaphthalene-1-sulfonyl(Dns)-Phe-Leu-Arg and endothelin I by releasing the COOH-terminal amino acid. The reaction was inhibited by diisopropyl fluorophosphate, benzyloxycarbonyl-Gly-Leu-Phe-CH2Cl, and p-chloromercuribenzenesulfonate, which inhibit the purified deamidase, but not by inhibitors of some other peptidases. The rate of hydrolysis of endothelin I in the soluble, 100,000 x g final supernatant of the homogenized smooth muscle cells was 2.1 mumol/h/mg and 3.1 mumol/h/mg for Dns-Phe-Leu-Arg. Thus, smooth muscles, platelets, and many other tissues which contain the deamidase can inactivate endothelin by cleaving the COOH-terminal tryptophan.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737744

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

2.  Clinical utility of whole-exome sequencing in rare diseases: Galactosialidosis.

Authors:  Carlos E Prada; Claudia Gonzaga-Jauregui; Rebecca Tannenbaum; Samantha Penney; James R Lupski; Robert J Hopkin; V Reid Sutton
Journal:  Eur J Med Genet       Date:  2014-04-24       Impact factor: 2.708

Review 3.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 4.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 5.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.

Authors:  A R Khan; M N James
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

Review 6.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

7.  Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131.

Authors:  Gabriel Birkus; Ruth Wang; Xiaohong Liu; Nilima Kutty; Holly MacArthur; Tomas Cihlar; Craig Gibbs; Swami Swaminathan; William Lee; Martin McDermott
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

8.  Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease.

Authors:  Alessandra d'Azzo; Erik Bonten
Journal:  Biochem Soc Trans       Date:  2010-12       Impact factor: 5.407

9.  Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells.

Authors:  S Zhang; J D McCarter; Y Okamura-Oho; F Yaghi; A Hinek; S G Withers; J W Callahan
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

10.  Proteolytic activation of human cathepsin A.

Authors:  Nilima Kolli; Scott C Garman
Journal:  J Biol Chem       Date:  2014-03-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.